CareMatrix — Pre-commercial procurement (PCP) to buy R&D (research and development) services to develop integrated care tools and services for people with multimorbidity.
Region Skåne, Kristianstad
This PIN provides early information about the expected starting date and purchase volume for a pre-commercial procurement (PCP) in the sector of Integrated Health Care, and about the open market consultation that is organised in preparation of this procurement.
The procurement aims to trigger testing and development of new solutions to anticipate and address the needs of people suffering from multimorbititiy, by ensuring timely service access, co-managed care journeys and transitions between specialties and sectors. It will address the white spaces between silo-based single-diagnosis treatment tracks, and the white spaces occurring in caregiver transitions.
Some of the main technical challenges to be addressed are: 20 % reduction in time spent for visits to care facilities and increased patient safety by 50 % fewer inter-organisational patient data-related incidents.
The procurement will take the form of a pre-commercial procurement (PCP) under which R&D service contracts will be awarded to a number of R&D providers in parallel in a phased approach. This will make it possible to compare competing alternative solutions.
Each selected operator will be awarded a framework agreement that covers 3 R&D phases.
The 3 phases are:
— solution design (expected to award contracts up to EUR 52 500 per awarded supplier*),
— prototyping (expected to award contracts up to EUR 420 000 per awarded supplier*),
— original development and validation and testing of a limited set of first products or services. (expected to award contracts up to EUR 1 050 000 per awarded supplier*).
After each phase, intermediate evaluations will be carried out to progressively to select the best of the competing solutions. The contractors with the best-value-for-money solutions will be offered a specific contract for the next phase.
Testing is expected to take place in Basque country(ES), Oslo-Viken (NO) and Skåne (SE). This testing may also serve as a first customer test reference for the contractors. The procurement is expected to start in 2022-07 and end in 2024-10.
The selected operators will retain ownership of the intellectual property rights (IPRs) that they generate during the PCP and will be able to use them to exploit the full market potential of the developed solutions i.e. beyond the procurement. The market potential is estimated at EUR 75 000 000 000 (across Europe).
* These are indicative estimates according to original budget and project plan.
Skåne län, Oslo, Viken, Spanien